The global Soliris (Eculizumab) market was valued at 387.68 Million USD in 2020 and will grow with a CAGR of 12.49% from 2020 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.In recent years, Solilis Asia Pacific market has developed rapidly. However, with the development of the economic situation in the Asia-Pacific region, other companies have entered the industry one after another; prices will decline in the next five years. Soliris is widely used in patients such as PNH and aHUS. PNH patients have the highest proportion of Soliris. Japan is the world`s largest consumer market, and China is the second largest consumer market after Japan. Market competition is not intense. Soliris (eculizumab) is the first and only drug approved for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH) or atypical hemolytic uremic syndrome (aHUS). PNH and aHUS It is caused by long-term uncontrolled activation of the complement component of the immune system. The FDA will not approve the biosimilar applications of Soliris until March 16, 2019; the length of the exclusivity period has been controversial.
By Market Verdors:
Alexion
By Types:
Plasma Exchange
Plasma Infusion
By Applications:
PNH
AHUS
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Soliris (Eculizumab) Market Size Analysis from 2022 to 2027
1.5.1 Global Soliris (Eculizumab) Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Soliris (Eculizumab) Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Soliris (Eculizumab) Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Soliris (Eculizumab) Industry Impact
Chapter 2 Global Soliris (Eculizumab) Competition by Types, Applications, and Top Regions and Countries
2.1 Global Soliris (Eculizumab) (Volume and Value) by Type
2.1.1 Global Soliris (Eculizumab) Consumption and Market Share by Type (2016-2021)
2.1.2 Global Soliris (Eculizumab) Revenue and Market Share by Type (2016-2021)
2.2 Global Soliris (Eculizumab) (Volume and Value) by Application
2.2.1 Global Soliris (Eculizumab) Consumption and Market Share by Application (2016-2021)
2.2.2 Global Soliris (Eculizumab) Revenue and Market Share by Application (2016-2021)
2.3 Global Soliris (Eculizumab) (Volume and Value) by Regions
2.3.1 Global Soliris (Eculizumab) Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Soliris (Eculizumab) Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Soliris (Eculizumab) Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Soliris (Eculizumab) Consumption by Regions (2016-2021)
4.2 North America Soliris (Eculizumab) Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Soliris (Eculizumab) Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Soliris (Eculizumab) Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Soliris (Eculizumab) Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Soliris (Eculizumab) Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Soliris (Eculizumab) Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Soliris (Eculizumab) Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Soliris (Eculizumab) Sales, Consumption, Export, Import (2016-2021)
4.10 South America Soliris (Eculizumab) Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Soliris (Eculizumab) Market Analysis
5.1 North America Soliris (Eculizumab) Consumption and Value Analysis
5.1.1 North America Soliris (Eculizumab) Market Under COVID-19
5.2 North America Soliris (Eculizumab) Consumption Volume by Types
5.3 North America Soliris (Eculizumab) Consumption Structure by Application
5.4 North America Soliris (Eculizumab) Consumption by Top Countries
5.4.1 United States Soliris (Eculizumab) Consumption Volume from 2016 to 2021
5.4.2 Canada Soliris (Eculizumab) Consumption Volume from 2016 to 2021
5.4.3 Mexico Soliris (Eculizumab) Consumption Volume from 2016 to 2021
Chapter 6 East Asia Soliris (Eculizumab) Market Analysis
6.1 East Asia Soliris (Eculizumab) Consumption and Value Analysis
6.1.1 East Asia Soliris (Eculizumab) Market Under COVID-19
6.2 East Asia Soliris (Eculizumab) Consumption Volume by Types
6.3 East Asia Soliris (Eculizumab) Consumption Structure by Application
6.4 East Asia Soliris (Eculizumab) Consumption by Top Countries
6.4.1 China Soliris (Eculizumab) Consumption Volume from 2016 to 2021
6.4.2 Japan Soliris (Eculizumab) Consumption Volume from 2016 to 2021
6.4.3 South Korea Soliris (Eculizumab) Consumption Volume from 2016 to 2021
Chapter 7 Europe Soliris (Eculizumab) Market Analysis
7.1 Europe Soliris (Eculizumab) Consumption and Value Analysis
7.1.1 Europe Soliris (Eculizumab) Market Under COVID-19
7.2 Europe Soliris (Eculizumab) Consumption Volume by Types
7.3 Europe Soliris (Eculizumab) Consumption Structure by Application
7.4 Europe Soliris (Eculizumab) Consumption by Top Countries
7.4.1 Germany Soliris (Eculizumab) Consumption Volume from 2016 to 2021
7.4.2 UK Soliris (Eculizumab) Consumption Volume from 2016 to 2021
7.4.3 France Soliris (Eculizumab) Consumption Volume from 2016 to 2021
7.4.4 Italy Soliris (Eculizumab) Consumption Volume from 2016 to 2021
7.4.5 Russia Soliris (Eculizumab) Consumption Volume from 2016 to 2021
7.4.6 Spain Soliris (Eculizumab) Consumption Volume from 2016 to 2021
7.4.7 Netherlands Soliris (Eculizumab) Consumption Volume from 2016 to 2021
7.4.8 Switzerland Soliris (Eculizumab) Consumption Volume from 2016 to 2021
7.4.9 Poland Soliris (Eculizumab) Consumption Volume from 2016 to 2021
Chapter 8 South Asia Soliris (Eculizumab) Market Analysis
8.1 South Asia Soliris (Eculizumab) Consumption and Value Analysis
8.1.1 South Asia Soliris (Eculizumab) Market Under COVID-19
8.2 South Asia Soliris (Eculizumab) Consumption Volume by Types
8.3 South Asia Soliris (Eculizumab) Consumption Structure by Application
8.4 South Asia Soliris (Eculizumab) Consumption by Top Countries
8.4.1 India Soliris (Eculizumab) Consumption Volume from 2016 to 2021
8.4.2 Pakistan Soliris (Eculizumab) Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Soliris (Eculizumab) Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Soliris (Eculizumab) Market Analysis
9.1 Southeast Asia Soliris (Eculizumab) Consumption and Value Analysis
9.1.1 Southeast Asia Soliris (Eculizumab) Market Under COVID-19
9.2 Southeast Asia Soliris (Eculizumab) Consumption Volume by Types
9.3 Southeast Asia Soliris (Eculizumab) Consumption Structure by Application
9.4 Southeast Asia Soliris (Eculizumab) Consumption by Top Countries
9.4.1 Indonesia Soliris (Eculizumab) Consumption Volume from 2016 to 2021
9.4.2 Thailand Soliris (Eculizumab) Consumption Volume from 2016 to 2021
9.4.3 Singapore Soliris (Eculizumab) Consumption Volume from 2016 to 2021
9.4.4 Malaysia Soliris (Eculizumab) Consumption Volume from 2016 to 2021
9.4.5 Philippines Soliris (Eculizumab) Consumption Volume from 2016 to 2021
9.4.6 Vietnam Soliris (Eculizumab) Consumption Volume from 2016 to 2021
9.4.7 Myanmar Soliris (Eculizumab) Consumption Volume from 2016 to 2021
Chapter 10 Middle East Soliris (Eculizumab) Market Analysis
10.1 Middle East Soliris (Eculizumab) Consumption and Value Analysis
10.1.1 Middle East Soliris (Eculizumab) Market Under COVID-19
10.2 Middle East Soliris (Eculizumab) Consumption Volume by Types
10.3 Middle East Soliris (Eculizumab) Consumption Structure by Application
10.4 Middle East Soliris (Eculizumab) Consumption by Top Countries
10.4.1 Turkey Soliris (Eculizumab) Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Soliris (Eculizumab) Consumption Volume from 2016 to 2021
10.4.3 Iran Soliris (Eculizumab) Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Soliris (Eculizumab) Consumption Volume from 2016 to 2021
10.4.5 Israel Soliris (Eculizumab) Consumption Volume from 2016 to 2021
10.4.6 Iraq Soliris (Eculizumab) Consumption Volume from 2016 to 2021
10.4.7 Qatar Soliris (Eculizumab) Consumption Volume from 2016 to 2021
10.4.8 Kuwait Soliris (Eculizumab) Consumption Volume from 2016 to 2021
10.4.9 Oman Soliris (Eculizumab) Consumption Volume from 2016 to 2021
Chapter 11 Africa Soliris (Eculizumab) Market Analysis
11.1 Africa Soliris (Eculizumab) Consumption and Value Analysis
11.1.1 Africa Soliris (Eculizumab) Market Under COVID-19
11.2 Africa Soliris (Eculizumab) Consumption Volume by Types
11.3 Africa Soliris (Eculizumab) Consumption Structure by Application
11.4 Africa Soliris (Eculizumab) Consumption by Top Countries
11.4.1 Nigeria Soliris (Eculizumab) Consumption Volume from 2016 to 2021
11.4.2 South Africa Soliris (Eculizumab) Consumption Volume from 2016 to 2021
11.4.3 Egypt Soliris (Eculizumab) Consumption Volume from 2016 to 2021
11.4.4 Algeria Soliris (Eculizumab) Consumption Volume from 2016 to 2021
11.4.5 Morocco Soliris (Eculizumab) Consumption Volume from 2016 to 2021
Chapter 12 Oceania Soliris (Eculizumab) Market Analysis
12.1 Oceania Soliris (Eculizumab) Consumption and Value Analysis
12.2 Oceania Soliris (Eculizumab) Consumption Volume by Types
12.3 Oceania Soliris (Eculizumab) Consumption Structure by Application
12.4 Oceania Soliris (Eculizumab) Consumption by Top Countries
12.4.1 Australia Soliris (Eculizumab) Consumption Volume from 2016 to 2021
12.4.2 New Zealand Soliris (Eculizumab) Consumption Volume from 2016 to 2021
Chapter 13 South America Soliris (Eculizumab) Market Analysis
13.1 South America Soliris (Eculizumab) Consumption and Value Analysis
13.1.1 South America Soliris (Eculizumab) Market Under COVID-19
13.2 South America Soliris (Eculizumab) Consumption Volume by Types
13.3 South America Soliris (Eculizumab) Consumption Structure by Application
13.4 South America Soliris (Eculizumab) Consumption Volume by Major Countries
13.4.1 Brazil Soliris (Eculizumab) Consumption Volume from 2016 to 2021
13.4.2 Argentina Soliris (Eculizumab) Consumption Volume from 2016 to 2021
13.4.3 Columbia Soliris (Eculizumab) Consumption Volume from 2016 to 2021
13.4.4 Chile Soliris (Eculizumab) Consumption Volume from 2016 to 2021
13.4.5 Venezuela Soliris (Eculizumab) Consumption Volume from 2016 to 2021
13.4.6 Peru Soliris (Eculizumab) Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Soliris (Eculizumab) Consumption Volume from 2016 to 2021
13.4.8 Ecuador Soliris (Eculizumab) Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Soliris (Eculizumab) Business
14.1 Alexion
14.1.1 Alexion Company Profile
14.1.2 Alexion Soliris (Eculizumab) Product Specification
14.1.3 Alexion Soliris (Eculizumab) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Soliris (Eculizumab) Market Forecast (2022-2027)
15.1 Global Soliris (Eculizumab) Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Soliris (Eculizumab) Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Soliris (Eculizumab) Value and Growth Rate Forecast (2022-2027)
15.2 Global Soliris (Eculizumab) Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Soliris (Eculizumab) Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Soliris (Eculizumab) Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Soliris (Eculizumab) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Soliris (Eculizumab) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Soliris (Eculizumab) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Soliris (Eculizumab) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Soliris (Eculizumab) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Soliris (Eculizumab) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Soliris (Eculizumab) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Soliris (Eculizumab) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Soliris (Eculizumab) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Soliris (Eculizumab) Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Soliris (Eculizumab) Consumption Forecast by Type (2022-2027)
15.3.2 Global Soliris (Eculizumab) Revenue Forecast by Type (2022-2027)
15.3.3 Global Soliris (Eculizumab) Price Forecast by Type (2022-2027)
15.4 Global Soliris (Eculizumab) Consumption Volume Forecast by Application (2022-2027)
15.5 Soliris (Eculizumab) Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
Overview of the Global Eculizumab Market:The report discusses everything a marketer requires before investing in the global Eculizumab Market during the forecast period 2023-2030. It provides detailed insight into current trends, market shares, market size, and sales value...
The global Soliris Intravenous market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this ...
The global Eculizumab market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field eva...
The global Soliris market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evalua...
The global Soliris (Eculizumab) market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this...
The global Soliris Drug market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field e...
Summary
The report forecast global Soliris market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021E-2026F due to coronavirus situation.
The report offers detailed coverage of Soliris industry and main market trends with impact of coronavirus. The ...
Summary
The report forecast global Soliris Intravenous market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021E-2026F due to coronavirus situation.
The report offers detailed coverage of Soliris Intravenous industry and main market trends with imp...
The global Soliris (Eculizumab) market was valued at 387.68 Million USD in 2020 and will grow with a CAGR of 12.49% from 2020 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market pl...
The research team projects that the Eculizumab market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027.
The prime objective of this report is to help the user unders...